Literature DB >> 1316490

Efficient production of human immunodeficiency virus proteins in transgenic mice.

P Jolicoeur1, A Laperrière, N Beaulieu.   

Abstract

Transgenic mice containing the complete human immunodeficiency virus (HIV) coding sequences fused to the mouse mammary tumor virus long terminal repeat were generated. They were found to produce high levels of authentic gag and env HIV proteins in several tissues known to support mouse mammary tumor virus-driven transcription. HIV proteins were also detected in serum and in body fluids (milk and epididymal secretions) known to be natural sites of retrovirus, and specifically of HIV, production. These results indicate that primary mouse cells from different tissues have the capacity to produce HIV proteins. These mice represent a novel animal model for HIV infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316490      PMCID: PMC241179     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  Type C viruses of wild mice: characterization and natural history of amphotropic, ecotropic, and xenotropic MuLv.

Authors:  M B Gardner
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

Review 2.  Pathogenesis of maedi-visna.

Authors:  M Dawson
Journal:  Vet Rec       Date:  1987-05-09       Impact factor: 2.695

Review 3.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

Review 4.  Mammary tumor viruses.

Authors:  D H Moore; C A Long; A B Vaidya; J B Sheffield; A S Dion; E Y Lasfargues
Journal:  Adv Cancer Res       Date:  1979       Impact factor: 6.242

5.  Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers.

Authors:  K Kinoshita; S Hino; T Amagaski; S Ikeda; Y Yamada; J Suzuyama; S Momita; K Toriya; S Kamihira; M Ichimaru
Journal:  Gan       Date:  1984-02

6.  Expression of a human immunodeficiency virus type 1 long terminal repeat/simian virus 40 early region fusion gene in transgenic mice.

Authors:  J Skowronski
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

7.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

Authors:  T A Stewart; P K Pattengale; P Leder
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

8.  Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome.

Authors:  G M Shaw; B H Hahn; S K Arya; J E Groopman; R C Gallo; F Wong-Staal
Journal:  Science       Date:  1984-12-07       Impact factor: 47.728

9.  Infection of rabbits with human immunodeficiency virus.

Authors:  G Filice; P M Cereda; O E Varnier
Journal:  Nature       Date:  1988-09-22       Impact factor: 49.962

10.  HTLV-III in the semen and blood of a healthy homosexual man.

Authors:  D D Ho; R T Schooley; T R Rota; J C Kaplan; T Flynn; S Z Salahuddin; M A Gonda; M S Hirsch
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

View more
  6 in total

1.  Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease.

Authors:  Z Hanna; D G Kay; M Cool; S Jothy; N Rebai; P Jolicoeur
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

2.  Murine AIDS is initiated in the lymph nodes draining the site of inoculation, and the infected B cells influence T cells located at distance, in noninfected organs.

Authors:  C Simard; M Huang; P Jolicoeur
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

3.  Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences.

Authors:  C Power; J C McArthur; R T Johnson; D E Griffin; J D Glass; S Perryman; B Chesebro
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

4.  Myristylation of Pr60gag of the murine AIDS-defective virus is required to induce disease and notably for the expansion of its target cells.

Authors:  M Huang; P Jolicoeur
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease.

Authors:  F P Thomas; C Chalk; R Lalonde; Y Robitaille; P Jolicoeur
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  The blocks to human immunodeficiency virus type 1 Tat and Rev functions in mouse cell lines are independent.

Authors:  B J Winslow; D Trono
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.